Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies.
Bladé
Joan
J
Hospital Clinic Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.
Rosiñol
Laura
L
D000686:Amyloidosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000276:immunology; D007146:Immunoglobulin lambda-Chains / Q000276:immunology; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D010265:Paraproteinemias / Q000188:drug therapy* / Q000276:immunology; D013792:Thalidomide / Q000008:administration & dosage*
D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; D007166:Immunosuppressive Agents; D013792:Thalidomide